These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7849681)

  • 21. Guideline update. VTE disease: which agents, and when.
    Holten KB; Merok J
    J Fam Pract; 2009 Mar; 58(3):E1. PubMed ID: 19284934
    [No Abstract]   [Full Text] [Related]  

  • 22. Initiation of oral anticoagulation after acute ischaemic stroke or transient ischaemic attack: timing and complications of overlapping heparin or conventional treatment.
    Audebert HJ; Schenk B; Tietz V; Schenkel J; Heuschmann PU
    Cerebrovasc Dis; 2008; 26(2):171-7. PubMed ID: 18628615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Are activated clotting times helpful in the management of anticoagulation with subcutaneous low-molecular-weight heparin?
    Henry TD; Satran D; Knox LL; Iacarella CL; Laxson DD; Antman EM
    Am Heart J; 2001 Oct; 142(4):590-3. PubMed ID: 11579347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antiphospholipid antibody syndrome: a priori a contraindication to kidney transplantation?].
    Rubenwolf P; Lopau K; Gerharz EW; Heidbreder E; Riedmiller H
    Aktuelle Urol; 2007 Mar; 38(2):132-6. PubMed ID: 17390275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heparin resistance and increased platelet activation in coronary surgery patients treated with enoxaparin preoperatively.
    Pleym H; Videm V; Wahba A; Asberg A; Amundsen T; Bjella L; Dale O; Stenseth R
    Eur J Cardiothorac Surg; 2006 Jun; 29(6):933-40. PubMed ID: 16675258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Conventional or low molecular weight heparin in the treatment of venous thromboembolic disease?].
    Ruiz Manzano J; Monreal M
    Med Clin (Barc); 1998 Nov; 111(18):697-9. PubMed ID: 9887434
    [No Abstract]   [Full Text] [Related]  

  • 27. Bridging of oral anticoagulation therapy for invasive procedures.
    Spyropoulos AC
    Curr Hematol Rep; 2005 Sep; 4(5):405-13. PubMed ID: 16131443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anticoagulant properties, clinical efficacy and safety of efegatran, a direct thrombin inhibitor, in patients with unstable angina.
    Klootwijk P; Lenderink T; Meij S; Boersma H; Melkert R; Umans VA; Stibbe J; Müller EJ; Poortermans KJ; Deckers JW; Simoons ML
    Eur Heart J; 1999 Aug; 20(15):1101-11. PubMed ID: 10413640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-molecular-weight heparin in outpatient treatment of DVT.
    Yeager BF; Matheny SC
    Am Fam Physician; 1999 Feb; 59(4):945-52. PubMed ID: 10068716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Another perspective on monitoring anticoagulation therapy.
    Burnakis TG
    Ann Pharmacother; 1995 Oct; 29(10):1045-6. PubMed ID: 8845545
    [No Abstract]   [Full Text] [Related]  

  • 31. Nomograms for the administration of unfractionated heparin.
    Grubb H; Lovett J; Kingman HM; Copplestone JA; Prentice AG
    Thromb Haemost; 2001 Mar; 85(3):565. PubMed ID: 11307835
    [No Abstract]   [Full Text] [Related]  

  • 32. [-Anticoagulant drugs-].
    Gulba DC
    Herz; 1996 Feb; 21(1):12-27. PubMed ID: 8647576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of a sliding scale protocol for heparin on the ability to maintain whole blood activated partial thromboplastin times within a desired range in hemodialysis patients.
    Low CL; Bailie G; Morgan S; Eisele G
    Clin Nephrol; 1996 Feb; 45(2):120-4. PubMed ID: 8846524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Therapeutic indications for acute venous thromboembolism. Current status and future perspectives].
    Prandoni P; Simioni P; Pagnan A
    Minerva Cardioangiol; 2003 Aug; 51(4):361-71. PubMed ID: 12900718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical considerations of heparinization.
    Cushinotto NM
    J Am Acad Nurse Pract; 1997 Jun; 9(6):273-6. PubMed ID: 9274247
    [No Abstract]   [Full Text] [Related]  

  • 36. [Administration of oral anticoagulants in heparinized patients].
    Blum J; Bondeli C; Grossman E; Müller L; Marbet GA; Duckert F
    Med Welt; 1982 Oct; 33(41):1436-8. PubMed ID: 7154915
    [No Abstract]   [Full Text] [Related]  

  • 37. Optimal weight base for a weight-based heparin dosing protocol.
    Yee WP; Norton LL
    Am J Health Syst Pharm; 1998 Jan; 55(2):159-62. PubMed ID: 9465981
    [No Abstract]   [Full Text] [Related]  

  • 38. Changes in the USP heparin monograph and implications for clinicians.
    Smythe MA; Nutescu EA; Wittkowsky AK
    Pharmacotherapy; 2010 May; 30(5):428-31. PubMed ID: 20411994
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical laboratory studies for the podiatric surgical patient.
    Arden SH
    J Foot Surg; 1976; 15(4):156-8. PubMed ID: 1025198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immediate anticoagulation in acute focal brain ischemia revisited: gathering the evidence.
    Chamorro A
    Stroke; 2001 Feb; 32(2):577-8. PubMed ID: 11157200
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.